Who We Are

In 1996, Grammy-nominated songwriter and philanthropist, Denise Rich, lived every parent’s worst fear as one of her three daughters, a beautiful 27-year-old actress and Hodgkin’s lymphoma survivor named Gabrielle, succumbed to acute myelogenous leukemia (AML). Gabrielle lost her battle, but her dream lives on in the work of the organization created in her memory, Gabrielle’s Angel Foundation for Cancer Research. It was Gabrielle’s idea to create a Foundation that would fund the best and brightest scientific investigators in the nation with the hope that less toxic treatments, and ultimately a cure, might be discovered. Her mother and sisters, Daniella and Ilona, believed the best way to honor Gabrielle’s memory was to turn their extraordinary grief into a positive force for others.

The mission of Gabrielle’s Angel Foundation for Cancer Research is to encourage the development of more effective therapies for patients with leukemia, lymphoma, and related cancers. The Foundation funds innovative clinical or basic science research that will lead to novel therapeutic approaches that could replace, or be used in combination with existing effective therapies. Such therapeutic approaches could include alternative or complementary medicine.

The Foundation funds research to improve the efficacy of cancer treatments, reduce their toxicity and improve the quality of life of patients with leukemia or lymphoma.

The Foundation also supports limited scientific interchange between select leaders in different areas of bio and integrative medical research, to develop unique and important collaborative efforts that will lead to improvements in the treatment and care of patients with leukemia and lymphoma.

In 2016, the Foundation celebrates 20 years of transformations in cancer treatment and care. We honor Gabrielle's legacy by funding the most cutting-edge, creative scientific ideas with an eye toward getting treatments from the bench, to the bedside, to a cure.